References
- Fukayama M, Hino R, Uozaki H. Epstein–Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma. Cancer Sci.99, 1726–1733 (2008).
- Haruma K, Komoto K, Kawaguchi H et al. Pernicious anemia and Helicobacter pylori infection in Japan: evaluation in a country with a high prevalence of infection. Am. J. Gastroenterol.90, 1107–1110 (1995).
- Nozaki K, Shimizu N, Inada K et al. Synergistic promoting effects of Helicobacter pylori infection and high-salt diet on gastric carcinogenesis in Mongolian gerbils. Jpn. J. Cancer Res.93, 1083–1089 (2002).
- Ikeda F, Doi Y, Yonemoto K et al. Hyperglycemia increases risk of gastric cancer posed by Helicobacter pylori infection: a population-based cohort study. Gastroenterology136, 1234–1241 (2009).
- Humar B, Blair V, Charlton A, More H, Martin I, Guilford P. E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man. Cancer Res.69, 2050–2056 (2009).
- Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: present status and future prospects in Japan. J. Gastroenterol.42, 1–15 (2007).
- Goodman KJ, Cockburn M. The role of epidemiology in understanding the health effects of Helicobacter pylori. Epidemiology12, 266–271 (2001).
- Hatakeyama M. Helicobacter pylori and gastric carcinogenesis. J. Gastroenterol.44, 239–248 (2009)
- Higashi H, Tsutsumi R, Muto S et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science295, 683–686 (2002).
- Takata S, Ito M, Yoshihara M et al. Host factors contributing to the discovery of gastric cancer after successful eradication therapy of Helicobacter pylori: preliminary report. J. Gastroenterol. Hepatol.22, 571–576 (2007).
- Ito M, Takata S, Tatsugami M et al. Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review. J. Gastroenterol.44, 365–371 (2009).
- Fukase K, Kato M, Kikuchi S et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet372, 350–352 (2008).
- Haruma K, Suzuki T, Tsuda T, Yoshihara M, Sumii K, Kajiyama G. Evaluation of tumor growth rate in patients with early gastric carcinoma of the elevated type. Gastrointest. Radiol.16, 289–292 (1991).
- Tsukuma H, Oshima A, Narahara H, Morii T. Natural history of early gastric cancer: a non-concurrent, long term, follow up study. Gut47, 618–621 (2000).
- Tahara E. Abnormal growth factor/cytokine network in gastric cancer. Cancer Microenviron.1, 85–91 (2008).
- Ito M, Tanaka S, Takata S et al. Morphological changes in human gastric tumours after eradication therapy of Helicobacter pylori in a short-term follow-up. Aliment. Pharmacol. Ther.21, 559–566 (2005).
- Gotoda T, Saito D, Kondo H et al. Endoscopic and histological reversibility of gastric adenoma after eradication of Helicobacter pylori. J. Gastroenterol.34(Suppl. 11), 91–96 (1999).
- Wu CY, Kuo KN, Wu MS, Chen YJ, Wang CB, Lin JT. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology137(5), 1641–1648.e1-2 (2009).
- Shimatani T, Inoue M, Iwamoto K et al. Prevalence of Helicobacter pylori infection, endoscopic gastric findings and dyspeptic symptoms among a young Japanese population born in the 1970s. J. Gastroenterol. Hepatol.20, 1352–1357 (2005).
- Kakinoki R, Kushima R, Matsubara A et al. Re-evaluation of histogenesis of gastric carcinomas: a comparative histopathological study between Helicobacter pylori-negative and H. pylori-positive cases. Dig. Dis. Sci.54, 614–620 (2009).
- Kato S, Matsukura N, Tsukada K et al.Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics. Cancer Sci.98, 790–794 (2007).
- Matsuda T, Marugame T, Kamo K et al. Cancer incidence and incidence rates in Japan in 2002: based on data from 11 population-based cancer registries. Jpn. J. Clin. Oncol.38, 641–648 (2008).